Lv11
9 积分 2020-11-08 加入
KRAS-G12D inhibitor HRS-4642 plus chemotherapy in advanced KRASG12D-mutant pancreatic cancer: a phase 1b/2 trial
25分钟前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
57分钟前
已完结
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer
1小时前
已完结
A neomorphic protein interface catalyzes covalent inhibition of RASG12D aspartic acid in tumors
2个月前
已完结
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer
2个月前
已完结
A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti-tumor efficacy in KRAS-driven cancers
2个月前
已完结
Differential activity of topotecan, irinotecan and SN-38 in fresh human tumour cells but not in cell lines
3个月前
已完结
Neoadjuvant nab-paclitaxel plus gemcitabine followed by modified FOLFIRINOX for resectable pancreatic cancer: A randomized phase 3 trial
4个月前
已完结
Neoadjuvant nab-paclitaxel plus gemcitabine followed by modified FOLFIRINOX for resectable pancreatic cancer: A randomized phase 3 trial
4个月前
已关闭
Neoadjuvant nab-paclitaxel plus gemcitabine followed by modified FOLFIRINOX for resectable pancreatic cancer: A randomized phase 3 trial
4个月前
已完结
皖公网安备34019202002308
